FES Primary Antibody

Item Information
Catalog #
Size
Price
Description

FES (feline sarcoma oncogene) and Fer are the only two members of a unique family of cytoplasmic protein tyrosine kinases. FES and Fer contain a central Src homology-2 (SH2) domain and a carboxy-terminal tyrosine kinase catalytic domain. They are structurally distinguished from other members of cytoplasmic protein tyrosine kinase subfamilies by the presence of amino-terminal Fer/CIP4 homology and coiled-coil domains. FES was originally identified as an oncogene from avian and feline retroviruses. Human c-Fes has been implicated in myeloid, vascular endothelial and neuronal cell differentiation. FES has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Mutations may activate the FES kinase and thereby contribute to cancer. However, recent data strongly suggests that the c-FES protein-tyrosine kinase is a tumor suppressor rather than a dominant oncogene in colorectal cancer.

Product Overview
Formulation
Ascitic fluid containing 0.03% sodium azide.
Storage
4°C; -20°C for long term storage
Product Image
Western Blot
Figure 1: Western blot analysis using FES mouse mAb against truncated FES recombinant protein.
Figure 1: Western blot analysis using FES mouse mAb against truncated FES recombinant protein.
Immunohistochemical analysis
Figure 2: Immunohistochemical analysis of paraffin-embedded human cerebrum tumor (A), endothelium of vessel (B), lymphocyte of thymus(C), showing cytoplasmic localization using FES mouse mAb with DAB staining.
Figure 2: Immunohistochemical analysis of paraffin-embedded human cerebrum tumor (A), endothelium of vessel (B), lymphocyte of thymus(C), showing cytoplasmic localization using FES mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.